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ABSTRACT 1 
 2 
Background: Rhode Island (RI) ninth graders report lifetime nonmedical use of prescription opioids 3 
(NMUPO) of 8.9%. NMUPO is associated with transition to heroin use, opioid overdose, and death.  4 
 5 
Objectives: Measure changes in 9th grade students' knowledge, confidence, perceptions of opioid use 6 
disorder prevention, overdose response with naloxone, treatment, and recovery, following the delivery 7 
of an interactive substance use disorder curriculum. 8 
 9 
Methods: Eight RI public high schools were recruited to participate.  Freshman in each school were 10 
administered identical surveys that collected demographic data, substance use and misuse knowledge, 11 
students' perceptions of substance misuse harm, reported drug use, and risk and protective behaviors 12 
before and after the curriculum.  13 
 14 
Results: Among 969 pre-intervention survey respondents, 19% reported use of marijuana, 3% heroin 15 
use, and 21% nonmedical use of prescription opioids.   Between the pre-intervention to the post-16 
intervention survey, significantly more students identified that addiction is a chronic brain disease (79% 17 
to 83%, p = 0.05), drug users are not responsible for their addiction (81% to 88%, p = 0.001), and that 18 
non-medical use of a prescription medication is use without a prescription (81% to 88%, p = 0.001). 19 
Improved confidence was also reported in identifying opioid withdrawal symptoms (26% to 45%, p < 20 
0.0001), identifying signs of an opioid overdose from 29% to 46% (p < 0.0001), and knowing when to 21 
administer naloxone (17% to 45%, p < 0.0001). Confidence to refer someone to treatment improved 22 
from 31% to 45% (p < 0.0001).   Logistic regression showed associations between mental health, peer 23 
use, parental affection, and academic performance factors as related to NMUPO. 24 
 25 
Conclusions: Students reported significant NMUPO prevalence. Ninth grade students' knowledge and 26 
confidence of opioid misuse, overdose response, and recovery resources increased following the 27 
delivery of a multi-modal interactive substance use disorder curriculum. Community, school, and 28 
student-level multifaceted interventions are needed to prevent reduce NMUPO among adolescents. 29 
 30 
Keywords:  opioids, misuse, prevention, pharmacy, adolescent 31 
Abbreviations: nonmedical use of prescription opioids (NMUPO), opioid use disorder (OUD), Rx for 32 
Addiction and Medication Safety (RAMS)  33 
Funding: This work was supported by the University of Rhode Island College of Pharmacy Healthcare 34 
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 38 
 39 
 40 
  41 
BACKGROUND  42 
 43 
In 2016, 881,000 or 4% of 12-17 year olds in the United States misused opioid pain relievers in the past 44 
year, defined as taking them not as directed, using someone else’s prescription, or using them for 45 
reasons other than intended.1 The most common opioid reported misused was hydrocodone, and the 46 
most common reason reported for misuse was to relieve physical pain. An average of 5% of Rhode 47 
Islanders aged 12 and older reported past year nonmedical use of prescription opioids (NMUPO) 48 
between 2012-2014, the highest in New England.2,3  While past year NMUPO is prevalent in 12-17 year 49 
olds (5%), it almost doubles in young adults aged 18-25 to 7.6%.4 In 2017, the percentage of students in 50 
9th grade that reported ever using prescription pain medicine non-medically was 8.9%, 10.6% of males 51 
and 6.3% females.5 Importantly, these measures are self-reported and subject to social desirability bias, 52 
and thus NMUPO may be underreported by as much as 35% in this population.6 53 
 54 
People who misuse opioids frequently obtained opioids from a friend or relative, or were prescribed 55 
them from one doctor.1 As opioid prescribing dramatically increased among adults and adolescent 56 
family members nationally, prescribing among children and adolescents was infrequent and 57 
unchanging.7 Still, Miech, et al. reported a 33% increase in the risk of NMUPO among young adults who 58 
were appropriately prescribed an opioid before 12th grade.8 NMUPO is associated with increasing rates 59 
of emergency room visits, inpatient admissions, transition to subsequent heroin use, increased risk of 60 
HIV and HCV infection, opioid-involved overdose, and death among adolescents.9–13 The risk of 61 
transition to heroin use is greatest in those that begin NMUPO earlier in adolescence. 14,15 62 
 63 
Encouragingly, the 2017 “Monitoring the Future,” study report, a longitudinal study of secondary school 64 
students’ reported use and impressions of drug risk and availability, shows improving trends regarding 65 
opioid misuse.16 12th graders report the lowest levels of non-heroin opioid use, and 8th, 10th, and 12th 66 
graders report decreasing opioid availability, and increasing or sustained perceived risk and disapproval 67 
of non-medical use of prescription opioids.16 Even as nonmedical use declines in this population, opioid 68 
use disorder diagnoses have increased,17 along with opioid overdose deaths, primarily attributed to 69 
heroin and fentanyl.18 The overall prescription opioid overdose age-adjusted death rate among 15-24 70 
year olds increased from 2% in 2015 to 2.6% in 2016, a 30% annual rate change, while the overall opioid 71 
overdose death rate (including heroin and fentanyl) increased from 7% to 9.3% over the same period, a 72 
32.9% change in rate. 19 The overall societal costs of NMUPO among all ages were estimated to be more 73 
than $55 billion per year.20 74 
 75 
Risk and Protective Factors 76 
 77 
Predictors of opioid misuse and use disorder have been identified among adolescents.21–25 These risk 78 
and protective factors become influential at various times during an adolescents development, and 79 
often relate to physiological changes or psychosocial concerns23,24,26,27 Categorization of individual, 80 
family, school and community factors are defined by the Office of the United States Surgeon General.21 81 
Examples include early initiation of opioid use, mental health problems, peer use, and misperception of 82 
normative use and risk of use for individual factors.  Lack of family support and academic success, as 83 
well as, increased availability of opioids are also associated predictors of misuse.  Social media use may 84 
also affect substance misuse as heavy use has been associated with higher levels of depression and 85 
anxiety and increased exposure to pro-substance use content that reinforces misuse. (Woods HC et al.  86 
Journal of Adolescence 2016; 51:41-49.  Tucker JS et al.  J Adoles Health 2013; 53:400-4.  Steers et al. 87 
Curr Addict Rep 2016; 3:343-348.  AAP Council on Communications and Media.  Media Use in School-88 
Aged Children and Adolescents.  Pediatrics 2016; 138: e20162592)  89 
For every $1 invested in youth prevention, researchers observed a $4 savings in health care costs and $7 90 
savings in law enforcement and other criminal justice costs.27 Once a child’s NMUPO is diagnosable as 91 
with an opioid use disorder (OUD), less than 25% of adolescents and young adults are offered and 92 
receive evidence-based, medication-first treatment, in part due to healthcare worker stigma.28,29 While 93 
treatment programs require sustainable funding to ensure adolescents manage their OUD and recover 94 
into adulthood, universal prevention programs have proven patient-, school-, community-level and 95 
economic benefits.30–32  An example of a universal approach, PROSPER (PROmoting School-community-96 
university Partnership to Enhance Resilience) model uses school- and family-based prevention 97 
programs. The PROSPER model has observed a decreased in prescription opioid and prescription drug 98 
misuse in adolescents both in the short- and long-term outcomes.30, 32 99 
 100 
This study evaluates a student pharmacist-delivered, opioid misuse prevention program developed for 101 
high school students and builds upon previous work for school-based prevention strategies for 102 
adolescents.33-36 The primary objective of this study was to assess high school students’ recall of 103 
knowledge of opioid misuse and awareness of medication safety considerations, including appropriate 104 
use, overdose identification and naloxone administration.  Secondarily, the study examined the effects 105 
of student substance misuse and its relationship to risk and protective factors.  Recognizing predictors of 106 
opioid misuse and use disorder, such as early exposure to opioids, experiencing a safe initial experience 107 
with a psychotropic medication, sibling and/or parent misuse of opioids, parental attention, peer 108 
NMUPO, depression, perceived stress, and academic problems in school, can help direct educational 109 
goals for prevention among this at-risk population.21,23–25,37 110 
 111 
METHODS 112 
  113 
The Rx for Addiction and Medication Safety (RAMS) program was a universal, opioid misuse prevention 114 
program developed by University of Rhode Island (URI) College of Pharmacy clinical practice-based 115 
faculty and reviewed and approved by an educational consultant with a Master in Education degree.   116 
The 3-hour curriculum provided 3-4 interactive educational sessions, including a focus on medication 117 
safety (i.e. safe use and storage, proper disposal of opioids), signs and symptoms and risk factors for 118 
opioid misuse and withdrawal, opioid overdose identification and response, and local treatment and 119 
recovery resources for adolescents and their families and friends.   The program used role-play, case 120 
scenarios, and the Frayer Model38 to help guide student learning and knowledge application to real-121 
world examples.  The program was also augmented by social media to reinforce information for high-122 
school students and faculty, as well as family members who joined the campaign.  123 
  124 
The RAMS program was piloted with a nonrandomized pre-post study design (Thiese et al.  125 
Observational and interventional study design types; an overview.  Biochem Med (Zagreb) 2014; 24:199-126 
210) in 8 Rhode Island public schools among 9th grade students.  Transition into high school increases 127 
the risk of misuse as freshmen face additional social and psychological challenges, and an environment 128 
with more drug exposure potential.27  The educational consultant of the program recruited schools over 129 
a 6-month period.  Monetary incentives were provided for school participation and additional stipends 130 
were offered for up to 2 high school students to attend a national drug prevention and leadership 131 
summer conference.   Prior to program delivery, school committee approval of the curriculum and 132 
corresponding study for all 8 schools was required.  Additionally, Rhode Island Department of Education 133 
approval was also needed.  Delivery of the program was unique because URI pharmacy students 134 
provided the majority of the curriculum to the schools.  Student pharmacists have successfully delivered 135 
a presentation on substance misuse focused on the neuroscience of addiction as a service learning 136 
activity to high school students.39 The authors noted several advantages of using student pharmacists to 137 
deliver the presentation, notably to increase the number of presentations delivered, and to have them 138 
delivered by relatable, typically younger individuals than the researchers. In this study, the 139 
presentations were positively received by both the presenters, the schools, and the students.39  Student 140 
delivery was decided upon for bolstering educational resources, but also to foster peer relationships 141 
with teens.40 Before receiving authorization to deliver the curriculum, students volunteered to complete 142 
a faculty-run, train-the-trainer program. The program included adolescent communication and life-skill 143 
development, as well as opioid safety and use disorder, overdose recognition and naloxone 144 
administration, and family/community outreach to prepare for on-school site presentation of the 145 
curriculum.    146 
  147 
Associated with program participation, 9th grade students were invited to complete a confidential, 148 
matched pre- and post-curriculum survey.   Parents received opt-out permission forms at least two 149 
weeks prior to survey administration and high-school students were required to assent directly before 150 
completing survey.  URI Institutional Review Board approval was also obtained prior to study initiation.  151 
College faculty developed survey to include items on risk and protective factors for substance misuse.  152 
Additional survey items included past nonmedical use of prescription opioids, alcohol and other illicit 153 
drugs, students’ perception of risk and/or harm from prescription opioids, and awareness of local and 154 
national treatment and recovery resources.  The survey also evaluated for changes in students’ 155 
knowledge of proper storage and disposal of prescription drugs, misuse knowledge and addiction 156 
awareness, overdose identification and naloxone administration.  Questions used were based on the 157 
2015 Youth Risk Behaviors Survey from the Centers for Disease Control and Prevention41 and the 2015 158 
Ontario Study Survey from the Canadian Centre for Addiction and Mental Health.42  A behavioral science 159 
research professor reviewed final survey for methodology and implemented it for administration via 160 
SurveyMonkey®.  High school students were provided the survey link and matched by collecting 161 
confidential identifiers (i.e. first 3 letters of mother’s maiden name, first 2 letters of student’s middle 162 
name and day of their birth).  Pre-survey administration occurred on the first day of curriculum prior to 163 
delivery and post-survey data was collected at least one month after curriculum conclusion.    164 
  165 
Statistical Analysis   166 
 167 
Bivariate analysis was completed separately among pre-intervention survey respondents and the 168 
matched pre-intervention and post intervention survey respondents.  Differences between the two 169 
groups of survey respondents (i.e., pre-survey and matched sample) were compared for each variable 170 
using a chi-square test or Fisher’s exact test, as appropriate.    Bivariate analysis was also completed for 171 
two dichotomous substance use outcome groups during the pre-survey: (1) non-medical use of 172 
prescription pain relief medications in the past 30 days; (2) prescription pain relief, attention-173 
deficient/hyperactivity disorder and sedative medications, over-the-counter cough medications and/or 174 
loperamide, marijuana and heroin in the previous 30 days.  The association of each possible risk factor 175 
with each substance use outcome was evaluated using a chi-square test or Fisher’s exact test, as 176 
appropriate.  For each of the substance use outcomes, univariate logistic regression was conducted for 177 
each independent variable to determine statistically significant associations with the outcome of 178 
interest.  All independent variables with P value <0.20 were included in the adjusted logistic regression 179 
model for each substance use outcome. Diagnostic tests for collinearity were performed between 180 
independent variables and diagnostics of model fit were examined, as guided by Akaike information 181 
criterion and the Hosmer Lemeshow test (David W. Hosmer & Stanley 182 
Lemesbow (2007) Goodness of fit tests for the multiple logistic regression 183 
model, Communications in Statistics - Theory and Methods, 9:10, 1043-184 
1069, DOI: 10.1080/03610928008827941) . Based on the adjusted models, the measure of 185 
association between outcome and each independent variable was determined by an estimated odds 186 
ratio with a corresponding 95% confidence interval. 187 
 188 
For the matched set of pre/post intervention respondent surveys, change in knowledge from the pre-189 
intervention survey to the post intervention survey was evaluated using McNemar’s test for paired data. 190 
For the continuous pre/post scores, each person serves as their own control, allowing for comparisons 191 
across the two groups because all time-invariant confounding is subtracted out by the individual level 192 
differencing and secular trends are less of a concern for this short of a follow-up period. All statistical 193 
tests were two-sided and performed at the 0.05 significance level.  All statistical analysis was performed 194 
using SAS 9.4 (Cary, NC.) 195 
 196 
RESULTS  197 
 198 
The RAMS program was piloted during the 2016-2017 academic year.  There were 969 adolescents who 199 
completed the pre-intervention survey (Table 1). The majority were 14 years old (45%), 52% were male, 200 
and 62% were white.  Most (80%) lived in one home only and spoke English at home (82%) and 54% 201 
lived with two parents and siblings. Twenty-four percent reported 5 or more hours of social media use 202 
per day and 22% received mostly C’s or lower in school. Forty-seven percent had a mother who 203 
graduated from college and 36% had a father who graduated from college. In their free time, 64% 204 
reported that at least one of their parents always knew where they were.  Among those who completed 205 
the pre-intervention survey, 9% reported use of marijuana, 1% reported heroin use, and 7% reported 206 
NMUPO.  207 
 208 
There were 527 adolescents in the matched sample and they were comparable to the pre-survey sample 209 
for the demographic factors in Table 1. The majority were 14 (49%) old, 48% were male, and 70% were 210 
white.  Most (80%) lived in one home only and spoke English at home (85%) and 58% lived with two 211 
parents and siblings. Twenty-four percent reported 5 or more hours of social media use per day and 17% 212 
received mostly C’s or lower in school. Fifty-two percent had a mother who graduated from college and 213 
39% had a father who graduated from college. In their free time, 68% reported that at least one of their 214 
parents always knew where they were. Among those in the matched sample, 7% reported use of 215 
marijuana, 0% reported heroin use, and 6% reported NMUPO.  The matched sample was comparable to 216 
the respondents at the pre-intervention survey, except more were white, and less received mostly C’s or 217 
lower. 218 
 219 
Pre-Post Changes in Substance Misuse Knowledge 220 
 221 
Among the matched sample of adolescents, there were significant increases in the number of correct 222 
responses reported for opioid misuse knowledge questions (Table 2).  From the pre-intervention survey 223 
to the post-intervention survey, significantly more students correctly identified that addiction is a 224 
chronic brain disease (79% to 83%, p = 0.05), drug users are not responsible for their addiction (81% to 225 
88%, p = 0.003), and drug users do not have weak characters (49% to 57%, p = 0.004).   The number of 226 
students who correctly identified drug misuse as accepting prescription medications from a friend and 227 
exceeding the recommended dose, increased (70% to 81%, p <0.0001 and 85% to 88%, p = 0.14, 228 
respectively).  Finally, there was a significant increase in the number of students who correctly identified 229 
that non-medical use of a prescription medication is defined as use without a prescription (81% to 88%, 230 
p = 0.001).  231 
 232 
Students were assigned a score for the number of correctly identified opioid withdrawal symptoms 233 
(observed score range, 0 to 12) and steps for managing an opioid overdose (observed score range, -4 to 234 
7; negative values represent only choosing incorrect responses). Students’ scores for opioid withdrawal 235 
symptoms increased from 5.9 correct responses (standard deviation (SD) = 3.6) to 6.3 (SD = 3.9; p = 236 
0.04) and scores for identifying the steps to manage an opioid overdose improved from 3.2 correct 237 
responses (SD = 1.7) to 3.9 (SD = 2.3; p < 0.0001).   238 
 239 
As knowledge increased, improved confidence was also reported in identifying opioid withdrawal 240 
symptoms (26% to 45%, p < 0.0001), identifying signs of an opioid overdose (29% to 46%, p < 0.0001), 241 
knowing when to administer naloxone (17% to 45%, p < 0.0001) and educating friends and family to 242 
recognize an opioid overdose and safely give naloxone when indicated (27% to 41%, p < 0.0001).  243 
Confidence in referral to treatment of friends and family with opioid misuse or use disorder also 244 
improved among 9th grade students (31% to 45%, p < 0.0001).    245 
 246 
Predictors of Substance Use at Pre-Survey 247 
 248 
The prevalence of non-medical use of prescription pain relief drugs, and non-medical use of any drugs 249 
captured in the pre-intervention survey are reported for each level of the demographic factors.  These 250 
findings are displayed in Supplementary Table 1. 251 
 252 
At the pre-intervention survey, reports of feeling depressed, under stress, peer use, and perception of 253 
low parental affection increased the odds of NMUPO (Table 3). Adolescents who reported feeling 254 
depressed a little or all the time had over 2 times the odds of reported NMUPO compared to those who 255 
were depressed none of the time, while adolescents who felt stressed or strained had over 5 times the 256 
odds of reported NMUPO compared to those that did not feel stressed at all.  Reported peer NMUPO in 257 
the past year increased the odds of 9th grade students by 1.9 compared to those who had friends who 258 
did not engage NMUPO.  Adolescents who reported their parents showed affection 2 times per year or 259 
less had twice the odds of reported NMUPO, compared to adolescents who reported their parents 260 
showed affection 1-2 times per month. 261 
 262 
At the pre-intervention survey, older age, being under stress, reported illegal drug sale attempts, peer 263 
use of marijuana, and low parental affection were associated with increased odds of non-medical use of 264 
drugs (Table 4).  Academic success was reported with decreased odds of non-medical use compared to 265 
earning lower grades (i.e., mostly C’s or lower).  Adolescents who were 17 years old had five times the 266 
increased odds of non-medical use of drugs compared to 14-year-old peers.  Adolescents who felt 267 
stressed or strained had over two times the odds of reported non-medical use of drugs when compared 268 
to those who were not stressed in the last month. Adolescents who reported illegal drug sale attempts 269 
had over three times the odds of reported non-medical use of drugs compared to those who did not 270 
report illegal drug sale attempts.  Those surveyed who that reported some to all of their closest friends 271 
used marijuana had twice the odds of reported non-medical use of drugs compared to those that 272 
reported none of their friends were using marijuana. Adolescents who reported their parents showed 273 
affection 2 times per year or less had over twice the odds of reported non-medical use of prescription 274 
pain relief drugs, compared to adolescents who reported their parents showed affection 1-2 times per 275 
month.  Grades of C’s or lower had 1.5 times the odds of reported non-medical use, where earning A’s 276 
decreased the odds by 50% compared to those who received mostly B’s.   277 
 278 
DISCUSSION 279 
 280 
The RAMS program provided a universal opioid misuse education program to adolescents uniquely 281 
through its curriculum design and delivery.  Freshmen students who participated improved their overall 282 
knowledge of opioid misuse and use disorder (i.e., addiction).  Improved knowledge and confidence 283 
were also observed for overdose identification and naloxone administration, as well as increased self-284 
confidence of knowing when treatment is indicated for a friend or family member and what resources 285 
are available for treatment and recovery.   286 
 287 
Educational prevention programs for teen substance misuse are abundant21,27,43 though most do not 288 
specifically target opioid misuse. 21,27,43 Programs are usually aimed for students using drug resistance 289 
and general social skills as prevention strategies27,33 Many others only target risk factors for general 290 
substance misuse or educate specifically on prescription medication safety.32,43 The RAMS curriculum 291 
provided drug resistance skills through awareness of opioid misuse dangers and situational social skills 292 
by way of role play, but its distinction is its inclusion of content on opioid safety, proper medication 293 
storage and disposal, treatment and recovery support for peers, and overdose recognition and reversal, 294 
including naloxone use.  Several states in addition to Rhode Island43 have proposed or passed substance 295 
use and misuse prevention high school curricula,45,46 but none have included naloxone education, 296 
despite policies that mandate or recommend naloxone be available in schools47. Adolescents can be 297 
successfully trained to administer the one-step intranasal formulation; 48 thus, naloxone education 298 
should be part of prevention curricula.  Harm reduction has been effective for alcohol and tobacco 299 
prevention, but related evidence for prescription or illicit drug use has not been studied.49  A 300 
multifaceted approach, such as RAMS, follows the prevention plan from the Substance Abuse and 301 
Mental Health Services Administration by addressing prescription drug misuse awareness, but 302 
additionally addresses medication safety considerations, harm reduction strategies, and treatment 303 
resources50 in 9th grade students.   304 
 305 
Seven and six percent of adolescents who completed the pre-intervention and matched survey, 306 
respectively, reported NMUPO.  Use among the study population corresponds with the 2017 self-307 
reported data from Rhode Island of 8.9% NMUPO among 9th grade students.5 Of those adolescents that 308 
state NMUPO, their associated risks were depression, stress, peer use, and perception of low parental 309 
affection.  Additional studies have observed similar mental health risk factors for NMUPO.23–25 Though 310 
self-medication for physical pain is the most common reason for misuse1, motives to self-treat 311 
depression and anxiety (i.e., emotional pain) have been observed in adolescents.23,24,51. Peer use and 312 
perception of low parental support both have been reported as known risks for NMUPO.21,37 Risks 313 
associated with overall substance misuse, including prescription opioids in the pre-intervention group 314 
were older age, lack of academic success, being approached to purchase drugs, as well as stress, peer 315 
use and lack of parental affection.  School-risk factors, such as academic failure as early as late 316 
elementary school, and community-risk factors of ease of drug access have both been observed in other 317 
studies and are risks defined by the Surgeon General.21,37 Age, it seems, may be a reflection of the early 318 
initiation of substance use, given the increasing odds with each year of age.21 RAMS curriculum currently 319 
focuses on peer use and drug access through normative education, misuse awareness, and proper 320 
storage and disposal.  A potential expansion is to further the discussion of self-medication risks and 321 
stress reduction strategies as outcomes indicate stress management and mental health resources may 322 
be warranted for schools.  The perceived lack of support among adolescents in the study highlights the 323 
need for family-centered prevention strategies in addition to a school-based approach.32,35 Parental 324 
involvement is essential for prevention strategies though parents and caregivers are difficult to recruit 325 
and retain in such programs.21,52 Use of social media may be a novel approach to reach and connect 326 
parents and teens; however, evidence is needed on its effectiveness.     327 
 328 
RAMS is delivered in several short, active-learning sessions with student pharmacists within the 329 
classroom, modified to fit the pilot school’s schedule.  This approach allows for pharmacy students to 330 
enhance the discussion and knowledge recall among adolescents as they are serving as peer instructors.  331 
Student pharmacists also provided advanced knowledge of prescription opioids, overdose education, 332 
including naloxone, which is in contrast to National Institute on Drug Abuse teen program that simply 333 
use online materials to serve as teacher facilitator guides.50,53 This is the first work to demonstrate 334 
comprehensive opioid misuse prevention education in a school-setting using pharmacy students.  335 
However, student pharmacists have provided opioid safety and overdose prevention to emergency 336 
department patients, and this program was found to be both feasible and improve patients knowledge 337 
of opioids. 54 Prevention education by student pharmacists in a school-setting through the RAMS 338 
program is achievable, improves knowledge of opioid misuse and its risks, and enhances students’ 339 
confidence to engagement in harm reduction strategies and support family and friends in treatment and 340 
recovery of opioid use disorder.   341 
 342 
Limitations  343 
 344 
Development of the opioid misuse curriculum was based on clinical faculty expertise and evidence-345 
based literature supporting the need for education on opioid misuse and increasing awareness of its 346 
risks and consequences, as well as safe use of opioids, proper medication storage and disposal, harm 347 
reduction strategies and treatment support.50,55 Therefore, our curriculum was not matched to a 348 
standard and may possess features not tailored to adolescent education.  Though in its design, the 349 
curriculum does provide drug resistance skills and normative education to students while additionally 350 
providing harm reduction strategies to help enhance competence skills training.   351 
  352 
Delivery of the curriculum proved to be difficult at times.  Pharmacy student recruitment for the train-353 
the-trainer program was robust; however, continued interest and motivation of pharmacy students to 354 
participate in more than 1 or 2 classroom sessions was limited.  Steps to enhance pharmacy student 355 
participation has been implementation for subsequent curriculum delivery in the form of student 356 
professional development funds.  Conversely, pharmacy students were unprepared for occasional 357 
behavioral issues within the classroom among high-school students.  Incentives provided to high schools 358 
were to be set aside to offset costs of having teachers present for classroom management and 359 
discipline.  However, some pharmacy students found classroom management of adolescents challenging 360 
and an obstacle to facilitating discussion of the program key elements.  Additional limitations include 361 
miscommunication of high school administration and staff which led to conflicts in delivery and timing of 362 
the curriculum, necessitating shortened duration of sessions and rescheduled sessions.  Certain schools 363 
also had different classroom needs, such as auditorium-style delivery, advisory times and rotating 364 
schedules adding to the challenge of presenting curriculum as an interactive program.  Challenges of 365 
existing school culture when implementing a novel curriculum is expected.  As the RAMS program 366 
continues within schools, scheduling and communication issues hopefully will subside as curriculum 367 
expectations will be known be all parties. 368 
  369 
Data collection also presented implementation challenges.  Surveys were tested for length prior to 370 
administration and found to be 10- to 15-minute duration.  Thus, pre-surveys were originally scheduled 371 
to be administered directly prior to the opening curriculum session.  However, some high school 372 
students took upwards of 45-60 minutes to complete the survey and arrangements had to be made to 373 
reschedule subsequent sessions.  In addition, youth had trouble with the confidential identifiers, 374 
particularly mother’s maiden name.  Therefore, the number of matched results were significantly 375 
reduced based on student understanding of the identifiers, as students and faculty were unprepared to 376 
explain what we assumed was common knowledge.  A new process for matched data collection will be 377 
implemented going forward with the removal of mother’s maiden name and replaced by street name 378 
where they reside.  Post surveys were to be administered 1-2 months after curriculum intervention.  379 
Nevertheless, some schools scheduled post surveys several months after curriculum, thus recall bias 380 
may be relevant due to different timing of the administration for post results.   381 
 382 
The responses to the survey were self-report and subject to reporting bias. In addition, based on the 383 
self-reported data, adolescents’ substance use and knowledge could be misclassified.6 The matched 384 
adolescents may not be representative of the study sample; thus, our results are subject to selection 385 
bias. In addition, secular trends may be present that our current approach did not consider, and our 386 
analyses could be subject to unmeasured confounding. The results from baseline are cross-sectional, so 387 
temporal sequence and causality are not possible to establish. Future longitudinal studies evaluating risk 388 
factors and subsequent opioid use initiation are warranted. In these studies, the intervention could be 389 
randomized to eliminate unmeasured confounding. Our pilot project evaluated this training among high 390 
school students in Rhode Island and these results may not be generalizable to a broader population 391 
without additional considerations. 392 
 393 
Future goals are to create a video booster curriculum to sustain knowledge gained and evaluate the 394 
disseminated or spillover effects of the RAMS training among high school students.  We plan to evaluate 395 
this program in additional Rhode Island schools to address gaps in opioid misuse prevention education 396 
in the state.  Further goals are to evaluate the longitudinal effect of prescription opioid misuse, measure 397 
the prevalence of heroin and other substance use among adolescents, with the objective to observe a 398 
decrease in use as a result of increased knowledge of opioid misuse, its risks, and treatment of opioid 399 
use disorder.   Additionally, we are creating a corresponding RAMS website for high school teachers and 400 
students, as well as parents and caregivers to expand upon the social media campaign.  The website will 401 
have video curriculum and additional teacher and parent resources to enhance recruitment and 402 
participation in prevention strategies.   403 
 404 
CONCLUSIONS 405 
 406 
Among adolescents surveyed the lifetime prevalence of NMUPO was 6%-7%.  NMUPO was associated 407 
with mental health problems, peer use and perceived lack of parental affection.  Students receiving 408 
multi-modal prevention education for prescription opioid misuse increased their knowledge and 409 
confidence in understanding of opioid misuse, overdose identification and its response, and recovery 410 
resources.  Inclusion of harm reduction strategies delivered by student pharmacists is a novel approach 411 
to prevention education.  Further evidence is needed to ensure the curricula decreases NMUPO and 412 
whether interventions for stress management and mental health, as well as family-centered strategies 413 
should be incorporated into the universal-school based program.   414 
 415 
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